Virtual Event: The evolving landscape for biosimilars
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Biosimilars were anticipated to be a solution to the soaring cost of prescription medicines to …
Read MoreTag: Video Chat
Virtual Event: Gene therapy’s next steps
Editor’s note: A recording of the event is embedded below. The first gene therapies have reached the market, and patients. But for such treatments to reach their potential, more advances …
Read More
Virtual event: The next battles in the war against HIV
Editor’s note: A livestream of the event is embedded below. Despite many strides in treatment and prevention, the HIV epidemic continues and disproportionately impacts women and men of color. STAT …
Read More
Virtual Event – Biotech: Where are we now?
Editor’s note: A recording of the event is embedded below. As the biotechnology industry holds its biggest conference, BIO Digital 2021, STAT brings you a look at how Covid-19 has …
Read More
Virtual Event: The ASCO Recap, Live!
Editor’s note: A recording of the event is embedded below. After the biggest meeting in cancer research, sit down with cancer’s biggest decision-maker: the director of the Food and Drug …
Read More
Virtual event: How artificial intelligence is transforming health care
AI has enormous potential to improve the quality of health care, enable early diagnosis of diseases, and reduce costs. But if implemented incautiously, AI can exacerbate health disparities, endanger privacy …
Read More
Virtual event: Increasing diversity in clinical trials
Editor’s note: A livestream of the event will be embedded below at 2 p.m. ET. The Covid-19 pandemic has thrown into relief the long-standing racial inequities in the U.S. health …
Read More
Virtual Event: What gene-targeted therapies mean for patients with cancer
Editors note: A livestream of the event will be embedded below at 1 p.m. ET. Targeted treatments for cancers with specific mutations have dramatically changed the lives of some people …
Read More
Virtual Event: Four former FDA commissioners discuss the agency’s future
Editor’s note: A recording of the event is embedded below. Nothing brings wisdom like experience. STAT convenes four former commissioners of the Food and Drug Administration to discuss the challenges …
Read More